Posted On: 09/09/2013 3:17:17 PM
Post# of 72440
Here is a post from IHUB that everyone should find quite interesting.
The poster, dmattingly62, doesn't post here but he was thanked wholeheartedly for getting this close and personal info direct from the horse's mouth.
Ok, I cornered Leo and the Doc lol. Some bullets for you all that I don't believe were in the presentation:
-no timeline on up listing. Value from this deal should be realized
- absolutely no reverse split to up list
- a lot of interested parties for Brilacidin
- European site still to be involved in P trial
- probably a 2 month process for FDA. They want a bridge study which will only take 3-4wks. They will be working the paperwork simultaneously
- autism drug on hold for now because of the landscape.
- moving fast on P and the new B
- a lot of research went into this deal. They are very excited about it. It was the stalking horse bid that enabled them to get Polymedix for so cheap and with stock
- cohort 5 is wrapping up. Not sure what dosing will be for 6
- Leo believes we are not near MTD yet. That the way DLT's are reported has to he understood. Ie: One patient experienced a lot of fatigue but they didn't think it was K related. But it still goes in. If a patient is nauseous or throws up before K injection, it is still recorded as a grade 2.
- Dr M confirmed with me that their is p21 activation . Preliminary testing has been done. But he was very cautious in his remarks. He said they really want to dot the I's and cross the T's. He actually used that expression. Lol
Leo and Dr Menon were both very excited and practically couldn't stop talking. They are ecstatic about this deal and the future. And the room was packed. All seats filled and people sitting on ledge as well as standing in the back.
The poster, dmattingly62, doesn't post here but he was thanked wholeheartedly for getting this close and personal info direct from the horse's mouth.
Ok, I cornered Leo and the Doc lol. Some bullets for you all that I don't believe were in the presentation:
-no timeline on up listing. Value from this deal should be realized
- absolutely no reverse split to up list
- a lot of interested parties for Brilacidin
- European site still to be involved in P trial
- probably a 2 month process for FDA. They want a bridge study which will only take 3-4wks. They will be working the paperwork simultaneously
- autism drug on hold for now because of the landscape.
- moving fast on P and the new B
- a lot of research went into this deal. They are very excited about it. It was the stalking horse bid that enabled them to get Polymedix for so cheap and with stock
- cohort 5 is wrapping up. Not sure what dosing will be for 6
- Leo believes we are not near MTD yet. That the way DLT's are reported has to he understood. Ie: One patient experienced a lot of fatigue but they didn't think it was K related. But it still goes in. If a patient is nauseous or throws up before K injection, it is still recorded as a grade 2.
- Dr M confirmed with me that their is p21 activation . Preliminary testing has been done. But he was very cautious in his remarks. He said they really want to dot the I's and cross the T's. He actually used that expression. Lol
Leo and Dr Menon were both very excited and practically couldn't stop talking. They are ecstatic about this deal and the future. And the room was packed. All seats filled and people sitting on ledge as well as standing in the back.
(0)
(0)Scroll down for more posts ▼
